Exploring potential additive effects of 5-fluorouracil, thymoquinone, and coenzyme Q10 triple therapy on colon cancer cells in relation to glycolysis and redox status modulation
Journal of the Egyptian National Cancer Institute,
Journal Year:
2025,
Volume and Issue:
37(1)
Published: March 10, 2025
Abstract
Background
To
investigate
the
anticancer
effects
of
5-Fluorouracil
(5-FU),
thymoquinone
(TQ),
and/or
coenzyme
Q10
(CQ10),
alone
and
combined,
in
HT29,
SW480,
SW620
human
colorectal
cancer
(CRC)
cell
lines.
Methods
Cell
cycle
progression
apoptosis
were
assessed
by
flow
cytometry.
Gene
protein
expression
molecules
involved
(BLC2,
survivin,
BAX,
Cytochrome-C,
Caspase-3),
(CCND1,
CCND3,
p21,
p27),
PI3K/AKT/mTOR/HIF1α
oncogenic
pathway,
glycolysis
(LDHA,
PDH,
PDHK1)
also
analysed
quantitative
RT-PCR
Western
blot.
Oxidative
stress
markers
(ROS/RNS,
MDA,
Protein
carbonyl
groups)
antioxidants
(GSH
CAT)
quantified
ELISA.
Results
All
treatments
resulted
depicted
arrest
apoptosis,
with
TQ
demonstrating
greater
efficacy
than
CQ10,
both
without
5-FU.
However,
5-FU/TQ/CQ10
triple
therapy
exhibited
most
potent
pro-apoptotic
activity
all
lines,
portrayed
lowest
levels
oncogenes
BCL2,
survivin)
highest
upregulation
tumour
suppressors
(p21,
p27,
Caspase-3).
The
showed
strongest
suppression
a
concurrent
increase
its
endogenous
inhibitors
(PTEN
AMPKα)
lines
used.
Additionally,
favoured
glucose
oxidation
upregulating
while
decreasing
LDHA
PDHK1
enzymes.
displayed
significant
decline
antioxidant
increases
oxidative
markers.
Conclusions
This
study
is
first
to
demonstrate
superior
compared
5-FU,
CRC
treatment.
Moreover,
this
report
reveal
improved
therapy,
potentially
through
promoting
phosphorylation,
attenuating
increasing
stress-induced
apoptosis.
Graphical
Human
colon
cells
(HT29,
&
SW620)
treated
individually
for
12h.
related
PI3K/AKT/mTOR
glycolytic
enzymes,
measured.
protocol
revealed
best
Language: Английский
Novel Perspectives in the Management of Colorectal Cancer: Mechanistic Investigations Into the Reversal of Drug Resistance via Active Constituents Derived From Herbal Medicine
Mingtang Zeng,
No information about this author
Yao Wang,
No information about this author
X. Tao
No information about this author
et al.
Phytotherapy Research,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Oct. 26, 2024
ABSTRACT
The
high
incidence
and
mortality
rate
of
colorectal
cancer
have
become
a
significant
global
health
burden.
Chemotherapy
has
been
the
traditional
treatment
for
demonstrated
promising
antitumor
effects,
leading
to
improvements
in
patient
survival.
However,
development
chemoresistance
poses
major
challenge
during
chemotherapy
cancer,
significantly
impeding
efficacy
affecting
prognosis.
Despite
variety
novel
anticolorectal
agents,
their
effectiveness
side
effects
vary,
possibly
due
complex
mechanisms
resistance
cancer.
Abnormal
drug
metabolism
or
protein
targets
are
most
direct
causes
resistance.
Further
studies
revealed
that
these
involve
biochemical
processes
such
as
altered
expression,
autophagy,
epithelial–mesenchymal
transitions.
Herbal
active
ingredients
offer
an
alternative
option
shown
promise
reversing
This
paper
aims
summarize
role
various
key
occurrence
maintenance
Additionally,
it
elaborates
on
action
herbal
article
also
discusses
limitations
opportunities
developing
drugs
based
medicine.
Language: Английский